Literature DB >> 10806153

Sputum cysteinyl leukotrienes increase 24 hours after allergen inhalation in atopic asthmatics.

A J Macfarlane1, R Dworski, J R Sheller, I D Pavord, A B Kay, N C Barnes.   

Abstract

We have used the relatively noninvasive technique of induced sputum to measure allergen-induced changes in the concentration of eicosanoid mediators in bronchial secretions from atopic asthmatics. Sputum induction was performed before and 24 h after inhalational allergen challenge in 14 atopic asthmatics who developed a late asthmatic reaction (LAR). Differential cell counts were made on sputum cytospins and eicosanoid (cysteinyl leukotrienes [cys LTs], prostaglandin D(2) [PGD(2)], and PGE(2)) concentrations were measured in the sputum supernatants. The percentage of eosinophils at baseline correlated with the concentration of cys LTs (r = 0.84, p < 0.001) but not prostanoid mediators. Allergen challenge produced a significant increase in the concentration of sputum cys LTs from 3. 45 ng/ml sputum to 11.95 ng/ml (p = 0.002), which correlated with the increase in sputum eosinophils (r = 0.55, p < 0.05). There were no significant changes in PGD(2) or PGE(2) concentrations in sputum supernatants in response to challenge. Thus, the noninvasive technique of induced sputum has been used to demonstrate increased cys LTs, but not prostanoids associated with LAR after allergen challenge. The correlation between eosinophil numbers and cys LT concentrations at baseline values and 24 h after allergen challenge is consistent with these cells being a principal source of cys LTs within the airways at these time points.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10806153     DOI: 10.1164/ajrccm.161.5.9906068

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  8 in total

1.  High- and low-dose allergen challenges in asthmatic patients using inhaled corticosteroids.

Authors:  Wha-Yong Lee; Thomas Southworth; Steven Booth; Dave Singh
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

Review 2.  Epithelial regulation of eicosanoid production in asthma.

Authors:  Teal S Hallstrand; Ying Lai; William R Henderson; William A Altemeier; Michael H Gelb
Journal:  Pulm Pharmacol Ther       Date:  2012-12       Impact factor: 3.410

3.  Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations.

Authors:  E Baraldi; S Carraro; R Alinovi; A Pesci; L Ghiro; A Bodini; G Piacentini; F Zacchello; S Zanconato
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

4.  Distinctive bronchial inflammation status in athletes: basophils, a new player.

Authors:  Beatriz Sastre; Mar Fernández-Nieto; María Jesús Rodríguez-Nieto; Erica Aguado; Joaquín Sastre; Victoria del Pozo
Journal:  Eur J Appl Physiol       Date:  2012-08-24       Impact factor: 3.078

5.  Contrasting effects of allergen challenge on airway responsiveness to cysteinyl leukotriene D(4) and methacholine in mild asthma.

Authors:  R I Ketchell; M D'Amato; M W Jensen; B J O'Connor
Journal:  Thorax       Date:  2002-07       Impact factor: 9.139

Review 6.  CRTH2 antagonists in asthma: current perspectives.

Authors:  Dave Singh; Arjun Ravi; Thomas Southworth
Journal:  Clin Pharmacol       Date:  2017-12-15

7.  Cysteinyl leukotriene E4 activates human group 2 innate lymphoid cells and enhances the effect of prostaglandin D2 and epithelial cytokines.

Authors:  Maryam Salimi; Linda Stöger; Wei Liu; Simei Go; Ian Pavord; Paul Klenerman; Graham Ogg; Luzheng Xue
Journal:  J Allergy Clin Immunol       Date:  2017-01-20       Impact factor: 10.793

8.  Role of leukotrienes in exercise-induced bronchoconstriction before and after a pilot rehabilitation training program.

Authors:  Ibrahim M El-Akkary; Zeinat El-Khouly Abdel-Fatah; Mervat El-Sayed El-Seweify; Gihan A El-Batouti; Ekhlas Abdel Aziz; Abdelnasser I Adam
Journal:  Int J Gen Med       Date:  2013-07-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.